Emerging insights into the role of IL-1 inhibitors and colchicine for inflammation control in type 2 diabetes.

Diabetol Metab Syndr · 2024 · PMC11197348 · PMID 38918878

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

documented a decreasing trend in diabetes development associated with increased duration of colchicine exposure [ 19 ].

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.